Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of$ 0.51. This compares to loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -29.41%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.63 per share when it actually produced a loss of $0.22, delivering a surprise of 65.08%.Over the last four quarters, the com ...